/AIDA

AIDA Stock - Aida Pharmaceuticals, Inc.

Q: What is the analyst price target for AIDA?

Analyst price target information is not currently available for AIDA.

Q: What is AIDA's market cap?

Market capitalization information is not currently available for AIDA.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for AIDA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2004

FY2005

FY2006

FY2007

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta17.62

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2007	FY2006	FY2005	FY2004
Revenue	$29.20M	$29.64M	$24.53M	$15.64M
Gross Profit	$14.69M	$15.56M	$16.19M	$11.02M
Gross Margin	50.3%	52.5%	66.0%	70.5%
Operating Income	$5.45M	$3.94M	$2.12M	$2.86M
Net Income	$2.74M	$1.45M	$1.47M	$1.64M
Net Margin	9.4%	4.9%	6.0%	10.5%
EPS	$0.10	$0.06	$0.06	$0.07

Company Overview

Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.

Frequently Asked Questions about AIDA

What is AIDA's current stock price?

Aida Pharmaceuticals, Inc. (AIDA) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for AIDA?

No analyst price targets are currently available for this stock.

What sector is Aida Pharmaceuticals, Inc. in?

Aida Pharmaceuticals, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is AIDA's market cap?

Aida Pharmaceuticals, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does AIDA pay dividends?

No, Aida Pharmaceuticals, Inc. does not currently pay a dividend to shareholders.